Arteria AI Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
94
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$30M
- Investors
-
9
Arteria AI General Information
Description
Developer of a contract lifecycle management platform designed for end-to-end digital contracting for large organizations. The company's platform helps users to generate, negotiate, and turn the executed contracts into data, enabling clients to diagnose problems, identify opportunities, and drive value for the organization.
Contact Information
Website
www.arteria.aiCorporate Office
- 152 King Street East
- Suite 300
- Toronto, Ontario M5A 1J3
- Canada
Corporate Office
- 152 King Street East
- Suite 300
- Toronto, Ontario M5A 1J3
- Canada
Arteria AI Timeline
Arteria AI Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Early Stage VC (Series B) | 26-Oct-2023 | $30M | Completed | Generating Revenue | ||
3. Early Stage VC | 12-May-2022 | Completed | Generating Revenue | |||
2. Accelerator/Incubator | 17-May-2021 | $11M | Completed | Generating Revenue | ||
1. Early Stage VC (Series A) | 22-Mar-2021 | $11M | $11M | Completed | Generating Revenue |
Arteria AI Comparisons
Industry
Financing
Details
Arteria AI Competitors (5)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Athennian | Venture Capital-Backed | Calgary, Canada | ||||
Contractbook | Venture Capital-Backed | Copenhagen, Denmark | ||||
SirionLabs | Venture Capital-Backed | Lehi, UT | ||||
eBrevia | Formerly VC-backed | New York, NY | ||||
Icertis | Venture Capital-Backed | Bellevue, WA |
Arteria AI Patents
Arteria AI Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-2781186-A1 | New phenylhydrazone derivatives and their use as pharmaceuticals | Inactive | 15-Dec-2009 | ||
AU-2010332980-A1 | New phenylhydrazone derivatives and their use as pharmaceuticals | Inactive | 15-Dec-2009 | ||
EP-2513100-A1 | New phenylhydrazone derivatives and their use as pharmaceuticals | Inactive | 15-Dec-2009 | ||
US-20120277436-A1 | Phenylhydrazone derivatives and their use as pharmaceuticals | Inactive | 15-Dec-2009 | ||
JP-2013513642-A | Novel phenylhydrazone derivatives and their use as pharmaceuticals | Pending | 15-Dec-2009 | C07D471/04 |
Arteria AI Executive Team (5)
Name | Title | Board Seat |
---|---|---|
Shelby Austin | Co-Founder & Chief Executive Officer | |
John Wallace | Chief Financial Officer | |
Jonathan Wong | Co-Founder & Chief Technology Officer | |
Abrar Huq | Co-Founder & Chief Revenue Officer | |
Anthony Lisi | Chief Of Staff |
Arteria AI Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
Jeff Richards | Notable Capital | Board Member |
Arteria AI Signals
Arteria AI Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Citicorp North America | Other | Minority | ||
Notable Capital | Venture Capital | Minority | ||
BDC Capital | Growth/Expansion | Minority | ||
Citi SPRINT | Corporate Venture Capital | Minority | ||
Fuse Incubator | Accelerator/Incubator |
Arteria AI FAQs
-
When was Arteria AI founded?
Arteria AI was founded in 2020.
-
Who is the founder of Arteria AI?
Shelby Austin, Jonathan Wong, and Abrar Huq are the founders of Arteria AI.
-
Who is the CEO of Arteria AI?
Shelby Austin is the CEO of Arteria AI.
-
Where is Arteria AI headquartered?
Arteria AI is headquartered in Toronto, Canada.
-
What is the size of Arteria AI?
Arteria AI has 94 total employees.
-
What industry is Arteria AI in?
Arteria AI’s primary industry is Business/Productivity Software.
-
Is Arteria AI a private or public company?
Arteria AI is a Private company.
-
What is Arteria AI’s current revenue?
The current revenue for Arteria AI is
. -
How much funding has Arteria AI raised over time?
Arteria AI has raised $50M.
-
Who are Arteria AI’s investors?
Citicorp North America, Notable Capital, BDC Capital, Citi SPRINT, and Fuse Incubator are 5 of 9 investors who have invested in Arteria AI.
-
Who are Arteria AI’s competitors?
Athennian, Contractbook, SirionLabs, eBrevia, and Icertis are competitors of Arteria AI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »